Álesson Adam Fonseca Andrade

Mr. Álesson Adam Fonseca Andrade

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2023 in Genes
Verified
Journal Article
Open access
PDF file
CACarolina Cabral Angelim
Carolina Cabral Angelim
LMLetícia Dias Martins
Letícia Dias Martins
ÁAÁlesson Adam Fonseca Andrade
Álesson Adam Fonseca Andrade
Fabiano MoreiraFabiano Moreira
Fabiano Moreira
JGJoão Farias Guerreiro
João Farias Guerreiro
GCGreice de Lemos Cardoso Costa
Greice de Lemos Cardoso Costa
Since the discovery of the polymorphic nature of the IFNL4 gene, its variants have been investigated and associated with several viral diseases, with an emphasis on hepatitis C. However, the impacts of these variants on mixed-race and native populations in the northern region of Brazil are scarce. We investigated three variants of the IFNL4 gene in populations from this location, which were among the 14 most frequent variants in worldwide populations, and compared the frequencies obtained to populational data from the 1000 Genomes Project, gnomAD and ABraOM databases. Our results demonstrate that mixed-race and native populations from the northern region of Brazil present frequencies like those of European and Asian groups for the rs74597329 and rs11322783 variants, and like all populations presented for the rs4803221 variant. These data reinforce the role of world populations in shaping the genetic profile of Brazilian populations, indicate patterns of illness according to the expressed genotype, and infer an individual predisposition to certain diseases.

Verified
Journal Article
Open access
PDF file
CACarolina Cabral Angelim
Carolina Cabral Angelim
ÁAÁlesson Adam Fonseca Andrade
Álesson Adam Fonseca Andrade
RSRenata Santos de Sousa
Renata Santos de Sousa
RCRaissa Lima Correa
Raissa Lima Correa
ASAmanda Roberta Vieira Sacramento
Amanda Roberta Vieira Sacramento
GCGreice de Lemos Cardoso Costa
Greice de Lemos Cardoso Costa
The rs12979860 polymorphism, related to the IFNL4 gene, is suggested as a factor that impacts fibrosis progression in hepatitis C virus (HCV) infection and exhibits a wide distribution pattern across global populations. In this retrospective cross-sectional study, we aimed to investigate the frequency of this variant in an Amazonian population from Brazil, as well as its association with liver fibrosis development and its staging in HCV carriers. Our results show a significant association of the TT genotype in the sample of patients with HCV (OR = 2.291; 95% CI = 1.088–4.826; p = 0.033) and the greater frequency of the T allele (62.1%), which is similar to the those of African populational groups. Populational genetics analysis showed significant differences in allele frequencies on global levels. The frequency of the C allele in the study population (37.8%) was like that of the African population (39.7%), and differed from all other populations, which ranged from 62.5% to 92.9%. These findings suggest that rs12979860 plays a role in susceptibility to hepatitis C. Additionally, they allow us to propose that the response to hepatitis C infection in this group may resemble that of the African population.

Verified
Journal Article
Open access
PDF file
ÁAÁlesson Adam Fonseca Andrade
Álesson Adam Fonseca Andrade
CACarolina Cabral Angelim
Carolina Cabral Angelim
LMLetícia Dias Martins
Letícia Dias Martins
ASAmanda Roberta Vieira Sacramento
Amanda Roberta Vieira Sacramento
RSRenata Santos de Sousa
Renata Santos de Sousa
GCGreice de Lemos Cardoso Costa
Greice de Lemos Cardoso Costa
It is heavily suggested that one IFNL4 gene polymorphism, rs12979860 (T/C), exerts influence on the outcome of HBV infection, with the rs12979860-T allele being classified as a risk predictor, and the rs12979860-C allele being classified as a protective one. This study investigated whether the rs12979860 IFNL4 gene polymorphism presented any association with the clinical severity for HBV carriers in an admixed population in Northern Brazil. A total of 69 samples were investigated from infected people from the city of Belém-Pará. The rs12979860-T allele was positively associated with HBV infection, suggesting a higher risk of chronicity. This research’s importance is that the polymorphism influence was investigated in a population of HBV carriers with a heterogeneous genetic profile, formed through the extensive admixture of different ethnic groups, including Europeans, Africans, and Natives with indigenous heritage. This analysis is particularly important since highly mixed populations do not always follow the same association patterns previously established by studies using populations classified as more genetically homogeneous, due to a different formation process.

Verified
Journal Article
Open access
PDF file
RSRenata Santos de Sousa
Renata Santos de Sousa
LCLorena de Carvalho Corrêa
Lorena de Carvalho Corrêa
FMFabiola Santos da Silva Matos
Fabiola Santos da Silva Matos
SMSamia Meneses
Samia Meneses
MPMarcos Daniel Mendes Padilha
Marcos Daniel Mendes Padilha
RFRosimar Neris Martins Feitosa
Rosimar Neris Martins Feitosa
Coinfection between hepatitis C virus (HCV) and human T-lymphotropic virus 1/2 (HTLV-1/2) remains poorly investigated in the Northern Region of Brazil despite its clinically important condition. The objective of this study was to determine the prevalence and describe the epidemiological and behavioral risk factors for HCV/HTLV-1/2 coinfection in Belém, Pará. This observational, descriptive, and cross-sectional study analyzed 192 samples from patients previously diagnosed with HCV: 127 participants recruited between May 2023 and June 2025 and 65 samples previously stored in the Virology Laboratory of UFPA. Data were collected through a structured survey. Serological screening for HTLV-1/2 was performed by enzyme-linked immunosorbent assay (ELISA) and confirmed by INNO-LIA and molecular biology (qPCR). HCV/HTLV-1/2 coinfection was observed in 4 individuals (2.1%), of whom 1.6% had HCV/HTLV-1 coinfection and 0.5% HCV/HTLV-2. There was no statistically significant association when comparing the sociodemographic, clinical characteristics, or risk factors of HCV monoinfected and HCV/HTLV-1/2 coinfected individuals. Although the results show a low prevalence of HTLV-1/2 and HCV coinfection in Belém do Pará, they still reinforce the importance of including HTLV in testing protocols for patients with hepatitis C in the North region of Brazil.